A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Clinical trial NCT06084962 · RECRUITING

Trial details

NCT number: NCT06084962
Sponsor: He Huang
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapse/Refractory Multiple Myeloma

Start date: 2023-10-20
Primary completion: 2026-10-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.